Drug Insight: continuous dopaminergic stimulation in the treatment of Parkinson's disease
Nature Clinical Practice Neurology · 2006-07 · 2 (7) · 382-392
DOI: 10.1038/ncpneuro0222 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nature Clinical Practice Neurology, 2006-07. Verfasst von C Warren Olanow und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mount Sinai School of Medicine, New York, NY 10029, USA. warren.olanow@mssm.edu. Die Arbeit wurde bisher 120-mal zitiert (Crossref) und nennt 91 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Mount Sinai School of Medicine, New York, NY 10029, USA. warren.olanow@mssm.edu
Zitieren
APA
Olanow, C. W., Obeso, J. A., & Stocchi, F. (2006). Drug Insight: continuous dopaminergic stimulation in the treatment of Parkinson's disease. Nature Clinical Practice Neurology, 2(7), 382-392. https://doi.org/10.1038/ncpneuro0222
Vancouver
Olanow CW, Obeso JA, Stocchi F. Drug Insight: continuous dopaminergic stimulation in the treatment of Parkinson's disease. Nature Clinical Practice Neurology. 2006;2(7):382-392. doi:10.1038/ncpneuro0222
BibTeX
@article{Olanow2006,
author = {Olanow, C Warren and Obeso, José A and Stocchi, Fabrizio},
title = {Drug Insight: continuous dopaminergic stimulation in the treatment of Parkinson's disease},
journal = {Nature Clinical Practice Neurology},
year = {2006},
volume = {2},
number = {7},
pages = {382--392},
doi = {10.1038/ncpneuro0222}
}
EUVIMED